Global AI in Digital Pathology Market By Type (Whole Slide Imaging, Image Analysis-Informatics), By Application (Pharma & Biotech Companies, Hospital & Diagnostic Centers), By Region, And Segment Fore...

The Global AI in Digital Pathology Market was valued at USD 0.38 billion in 2023 and it is poised to grow beyond USD 0.68 billion by the end of 2030; registering a CAGR of 8.65% during the forecast period of 2024-2030.

Digital pathology deals with the acquisition, management, sharing, and interpretation of pathology information in a digital pattern. In this technology, glass slides are converted into digital slides using scanning device. It allows pathologists to view and analyze these digital slides instead of using microscope. Artificial Intelligence (AI) significantly improves digital pathology by providing solutions for automated analysis, improving diagnostic accuracy, and reducing time and efforts.

Premium Insights

Global AI in Digital Pathology Market Dynamics

Market Drivers

Increasing pathology services worldwide;

-          Rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes due to change in lifestyle and packaged food is the key driving factor behind the increasing pathology services. This increases the pressure on pathologists. Digital pathology has immediate impacts for pathologists, labs, and health systems with greater field of view, slide preservation, distance analysis, greater efficiency etc.

Benefits of AI in Digital Pathology;

-          Artificial Intelligence (AI) integration into digital pathology offers numerous advantages, enhancing diagnostic accuracy, efficiency, and overall healthcare quality.

-          Improved Diagnostic Accuracy;

-          Increased Efficiency

-          Enhanced Workflow and Productivity

-          Decision Support

-          Enhanced Education and Training.

Market Restraint

High operational cost of AI in pathology;

-          AI in digital pathology encompasses a wide range of applications, from enhancing diagnostic accuracy and automating routine tasks that saves time. Automation, image analysis, scanners are technologies requires high operational costs. This can be a major barrier to widespread adoption of AI in digital pathology.

Market Opportunities

Rising funding initiatives in overall healthcare industry;

-          After COVID-19 pandemic, the awareness about healthcare and role of technology in healthcare has increased. Application of AI in healthcare can help address issues of high barriers to access to healthcare facilities. This can be achieved through implementation of use cases such as AI driven diagnostics, personalized treatment, early identification of potential pandemics, and imaging diagnostics, among others. Many governments are investing in healthcare sector to improve healthcare accessibility and affordability. For instance, Government of India aims to increase healthcare spending to 3% of country's GDP by 2022. In addition, data and AI in healthcare have the potential to add 25 USD TO 30 USD Billion to India's GDP by 2025.

AI in Digital Pathology Market by Component Insights:

Based on component segment, the market is segmented into Software, Scanners and Others. Software segment dominated the market due to rapidly growing digitalization in pathology. The software segment offers several benefits such as high adaptability, automation etc.

AI in Digital Pathology Market by Application Insights:

Based on application segment, the market is categorized into diagnosis, research and others. Diagnosis segment hold the highest market share i.e. more than 40% due to the increasing pathology services worldwide.

Market By region Insights

The North America AI in digital pathology market is expected to be the fastest growing and currently dominating due to the early adoption of technology in the region. North America, particularly the United States, has a well-developed healthcare infrastructure that is conducive to the integration of advanced technologies. Hospitals, research institutions, and diagnostic labs are equipped with the necessary resources and infrastructure to adopt AI-based solutions.

Competitive Scenario:

Major players operating in the global AI in Digital Pathology market include Roche, Leice Biosystems, Hamamatsu Photonics, Koninklijke Philips, 3D Hsitech, Apollo Enterprises Imaging, Xifin, Huron Digital Pathology, Vision pharm, Corista, Indica Labs.

Scope of Work – Global AI in Digital Pathology Market

Market Segmentation

·         Based on Component

o   Software

o   Scanners

o   Others

·         Based on Neural Network

o   Generative adversarial networks (GANs)

o   Convolutional neural networks (CNNs)

o   Recurrent neural networks (RNNs)

o   Others

·         Based on Application

o   Diagnosis

o   Research

o   Others

·         Based on End-user

o   Academic Institution

o   Hospitals/Healthcare Institutions

o   Laboratoeries

o   Others

·         Based on region

o   North America (U.S., Canada)

o   Europe (Germany, France, Italy, Spain, UK, Rest of Europe)

o   Asia-Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia-Pacific)

o   Latin America (Brazil, Argentina, Mexico, and Rest of LAMEA)

o   Middle East & Africa (Saudi Arabia, UAE, Qatar Bahrain, South Africa, Rest of MEA)

Frequently Asked Question

Q. What is the current market size of the Global AI in Digital Pathology Market?

Answer. The global AI in Digital Pathology market size was estimated at USD 0.38 billion in 2023 and is expected to grow beyond USD 0.68 billion in 2030, registering a CAGR of 8.65% during the forecast period of 2023-2030.

Q. What is the major growth driver of the Global AI in Digital Pathology Market?

Answer. The growth of the global AI in Digital Pathology market is mainly driven by increasing pathology services worldwide.

Q. Which is the largest region during the forecast period in the Global AI in Digital Pathology Market?

Answer.  North America region accounted for largest market share in the global AI in Digital Pathology market in 2022.

Q. Which segment accounted for the largest market share in Global AI in Digital Pathology Market?

Answer. Based on application, Diagnosis segment dominates the AI in Digital Pathology market.

Q. Who are the key market players in the Global AI in Digital Pathology Market?

Answer. Roche, Leice Biosystems, Hamamatsu Photonics, Koninklijke Philips, 3D Hsitech, Apollo Enterprises Imaging, Xifin, Huron Digital Pathology, Vision pharm, Corista, Indica Labs are the key players in this market that are shaping the growth trajectory of this market.